Bank of America
BOLT icon

Bank of America’s Bolt Biotherapeutics BOLT Stock Holding History

Bank of America’s Portfolio BOLT Stock Details BOLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-31
Closed -$169 – 5857
2025
Q4 		$169 Hold
31
– – ﹤0.01% 6731
2025
Q3 		$165 Sell
31
-251
-89% -$1.39K ﹤0.01% 7763
2025
Q2 		$1.63K Buy
282
+1
+0.4% +$7 ﹤0.01% 7459
2025
Q1 		$2.25K Hold
281
– – ﹤0.01% 7323
2024
Q4 		$3.01K Sell
281
-19
-6% -$230 ﹤0.01% 7153
2024
Q3 		$3.89K Buy
300
+269
+868% +$3.71K ﹤0.01% 7054
2024
Q2 		$471 Hold
31
– – ﹤0.01% 7373
2024
Q1 		$879 Hold
31
– – ﹤0.01% 7218
2023
Q4 		$703 Hold
31
– – ﹤0.01% 7243
2023
Q3 		$653 Hold
31
– – ﹤0.01% 7288
2023
Q2 		$804 Sell
31
-558
-95% -$17.7K ﹤0.01% 7277
2023
Q1 		$16.4K Buy
589
+549
+1,373% +$16.1K ﹤0.01% 6809
2022
Q4 		$1.04K Hold
40
– – ﹤0.01% 7337
2022
Q3 		$1K Sell
40
-261
-87% -$10.8K ﹤0.01% 7649
2022
Q2 		$13K Sell
301
-239
-44% -$9.28K ﹤0.01% 7313
2022
Q1 		$29K Sell
540
-2,406
-82% -$162K ﹤0.01% 7381
2021
Q4 		$288K Buy
2,946
+1,910
+184% +$363K ﹤0.01% 6268
2021
Q3 		$262K Buy
1,036
+521
+101% +$147K ﹤0.01% 6109
2021
Q2 		$160K Sell
515
-409
-44% -$166K ﹤0.01% 6237
2021
Q1 		$608K Buy
+924
New +$601K ﹤0.01% 5212

Other funds holding BOLT

SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America's BOLT Position: Q1 2026 in Review

Bank of America sold out of Bolt Biotherapeutics (BOLT) in Q1 2026, closing a stake of 31 shares — an estimated $169 sold.

Bank of America first reported a position in BOLT in Q1 2021 and held it in 20 quarters. The position peaked at $608K in Q1 2021. 24 funds tracked by Wall St. Rank hold BOLT as of Q1 2026.

  • Bank of America reported no remaining Bolt Biotherapeutics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 31 Bolt Biotherapeutics shares in Q1 2026, an estimated $169.
  • Bank of America first reported a position in Bolt Biotherapeutics in Q1 2021 and held it in 20 quarters.
  • Bank of America's Bolt Biotherapeutics position peaked at $608K in Q1 2021.
  • 24 funds tracked by Wall St. Rank held Bolt Biotherapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.